{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:19:07Z","timestamp":1784074747286,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejmech.2021.113337","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:34:15Z","timestamp":1614684855000},"page":"113337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections"],"prefix":"10.1016","volume":"216","author":[{"given":"Hang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-zuo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-bi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113337_bib1","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Csh. Perspect. Med."},{"key":"10.1016\/j.ejmech.2021.113337_bib2","first-page":"11","article-title":"Emerging Threats in antifungal-resistant fungal pathogens","volume":"3","author":"Dominique","year":"2016","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2021.113337_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","volume":"34","author":"Antinori","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113337_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2021.113337_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2017.1328279","article-title":"Drug development challenges and strategies to address emerging and resistant fungal pathogens","volume":"15","author":"Mccarthy","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2021.113337_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on antifungal drug resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr. Clin. Micro. Rpt."},{"key":"10.1016\/j.ejmech.2021.113337_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2021.113337_bib8","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","article-title":"The biology and chemistry of antifungal agents: a review","volume":"20","author":"Kathiravan","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib9","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging new targets for the treatment of resistant fungal infections","volume":"61","author":"Liu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2018.11.005","article-title":"Chemical preparation, biological evaluation and 3D-QSAR of ethoxysulfuron derivatives as novel antifungal agents targeting acetohydroxyacid synthase","volume":"162","author":"Wu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib11","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acsinfecdis.0c00229","article-title":"Herbicides that target acetohydroxyacid synthase are potent inhibitors of the growth of drug-resistant Candida auris","volume":"6","author":"Agnew-Francis","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113337_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182018000562","article-title":"CYP51 as drug targets for fungi and protozoan parasites: past, present and future","volume":"145","author":"Lepesheva","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2021.113337_bib13","article-title":"Fungal Lanosterol 14\u03b1-demethylase: a target for next-generation antifungal design","volume":"1868","author":"Monk","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113337_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-198019010-00002","article-title":"Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections","volume":"19","author":"Heel","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2021.113337_bib15","article-title":"The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113337_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fbr.2018.05.001","article-title":"Fungal cytochrome P450 protein Cyp51: what we can learn from its evolution, regulons and Cyp51-based azole resistance","volume":"32","author":"Song","year":"2018","journal-title":"Fungal Biol. Rev."},{"key":"10.1016\/j.ejmech.2021.113337_bib17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1039\/C7MD00112F","article-title":"Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration","volume":"8","author":"Zhang","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2021.113337_bib18","first-page":"1","article-title":"New insights on the antibacterial efficacy of miconazole in\u00a0vitro","author":"Nenoff","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ejmech.2021.113337_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"J.\u00a0Perfect, Azole antifungals: 35 years of invasive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti-Infe"},{"key":"10.1016\/j.ejmech.2021.113337_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112360","article-title":"Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents","volume":"198","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib21","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s11696-017-0239-z","article-title":"Design, synthesis and antifungal activity of novel selenochroman-4-one derivatives","volume":"71","author":"Xu","year":"2017","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2021.113337_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126726","article-title":"Design, synthesis and biological evaluation of novel semicarbazone selenochroman-4-ones hybrids as potent antifungal agents","volume":"29","author":"Xu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113337_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acsinfecdis.9b00197","article-title":"Drug repurposing of haloperidol: discovery of new benzocyclane derivatives as potent antifungal agents against cryptococcosis and candidiasis","volume":"6","author":"Ji","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113337_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2019.05.047","article-title":"Design, synthesis, and structure-activity relationship studies of L-amino alcohol derivatives as broad-spectrum antifungal agents","volume":"177","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib25","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1039\/C8OB00897C","article-title":"Anti-staphylococcal biofilm activity of miconazoctylium bromide","volume":"16","author":"Tessier","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib26","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.jmedchem.6b01203","article-title":"Tackling fungal resistance by biofilm inhibitors","volume":"60","author":"Wu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113337_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtemb.2014.08.001","article-title":"Diphenyl diselenide (PhSe)2 inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability","volume":"29","author":"Rosseti","year":"2015","journal-title":"J.\u00a0Trace Elem. Med. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:26:32Z","timestamp":1759328792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"alternative-id":["S0223523421001860"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113337","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113337"}}